8-K: Solsence Appoints New CEO, CFO Amid Strategic Shift

Solsence, Inc. announces key leadership changes, promoting Kevin Cureton to CEO and appointing Laura Riffner as CFO, as Jess Jankowski transitions to Board Advisor.

Summary

• Solsence, Inc. has appointed Kevin Cureton as its new President and Chief Executive Officer, effective September 3, 2025. Mr. Cureton, age 64, previously served as Chief Operating Officer since 2019.
• Laura Riffner, age 53, has been appointed Chief Financial Officer, effective September 3, 2025. Ms. Riffner brings extensive financial experience from Nagase America and Paxton/Patterson.
• Jess Jankowski, the former Chief Executive Officer and Chief Financial Officer, will transition to a Board Advisor role until his retirement on November 21, 2025.
• These leadership changes are part of a broader strategic transformation for Solsence, which rebranded from Nanophase Technologies in the first half of 2025 and uplisted to Nasdaq on April 8, 2025.
• The company aims to continue its focus on scientifically-driven health care solutions across beauty and life science categories, delivering high-performance skin care, sun care, and color cosmetics products.

Sentiment

Score: 9

Explanation: The filing conveys a highly positive sentiment, highlighting strategic leadership appointments, a successful rebranding, and a Nasdaq uplisting, all aimed at driving future innovation and growth. The new executives bring strong experience, and the transition is framed as a natural evolution for the company.

Positives

• Appointment of Kevin Cureton, an internal leader with a proven track record since 2019, to CEO ensures continuity and leverages existing company knowledge.
• Hiring Laura Riffner as CFO brings decades of financial expertise, including streamlining budget planning, enhancing operations, and overseeing acquisitions, which is expected to maximize profitability and efficiency.
• The strategic transformation, including rebranding from Nanophase Technologies and uplisting to Nasdaq, enhances the company's visibility and positions it for continued growth in key markets.
• Jess Jankowski's transition to Board Advisor provides continued guidance and ensures a smooth leadership handover until his retirement.

Risks

• Dependence on a limited number of key customers, with a risk of purchase order or supply agreement cancellations.
• Uncertain demand for, and acceptance of, the company's engineered materials, ingredients, and fully formulated products.
• Challenges related to manufacturing capacity and product mix flexibility in response to customer demand.
• Limited marketing experience could hinder product adoption and market penetration.
• Potential for changes in development and distribution relationships to impact business operations.
• Impact of competitive products and technologies on market share and profitability.
• Dependence on patents and the ability to protect proprietary information.
• Potential involvement in litigation and the costs associated with its resolution.
• Impact of any potential new government regulations that could be difficult or too costly to comply with.
• The ability to maintain an appropriate electronic trading venue for its securities.
• General industry and market conditions and growth rates could affect the company's performance.

Future Outlook

Solsence is positioned for continued success in delivering high-performance skin care, sun care, and color cosmetics products to its brand partners and consumers worldwide. The company aims to achieve long-term profitability and continue shaping the future of beauty through industry-leading skin health solutions.

Management Comments

• Jess Jankowski: "The elevation of Kevins role to President and Chief Executive Officer is a direct reflection of the growth and innovation achieved under his leadership. His partnership with Laura, a proven leader with a strong track record of maximizing profitability, marks a new era of growth for Solsence."
• Janet Whitmore (Chair of the Board): "As Jess transitions to his role as Board Advisor, we are delighted that Kevin will be our next CEO. During the companys rebranding and throughout his tenure at Solsence, Kevins strategic thinking, creativity and unbounded enthusiasm have made him an unshakeable leader. We are confident that his visionary approach will lead us to new heights."
• Kevin Cureton: "It has been a privilege to partner with Jess, whose deep history with the company and forward-thinking leadership has helped Solsence to become the innovative beauty science leader it is today. The companys evolution is a testament to his relentless commitment to growth through scientific excellence."
• Laura Riffner: "I’m eager to join the team at Solsence to continue to shape the future of beauty through innovative products that help improve skin health across the globe. I look forward to partnering with Kevin and the executive leadership team to build on the companys growth momentum and achieve long-term value creation for our shareholders."

Industry Context

Solsence's transformation from an advanced materials company (Nanophase Technologies) into a skin health innovator aligns with broader industry trends emphasizing scientific backing, innovation, and consumer-centric solutions in the beauty and life science sectors. The company's focus on redefining mineral-based sun protection and integrating protection, prevention, and treatment technologies positions it within the growing market for high-performance, science-backed personal care products.

Management Changes

Stakeholder Impact

• Shareholders: Expected to benefit from increased company visibility due to Nasdaq uplisting, potential for long-term value creation through strategic leadership, and continued focus on profitability.
• Employees: Experience leadership changes with an internal promotion to CEO and a new CFO, potentially leading to new strategic directions and operational efficiencies.
• Customers/Brand Partners: Anticipated to receive continued innovation and high-performance skin care, sun care, and color cosmetics products, reinforcing existing relationships.
• Suppliers/Vendors: Business relationships are expected to continue under the new leadership, with non-solicitation covenants in place for former executives.

Next Steps

• Kevin Cureton will lead the company as President and CEO, focusing on continued success in skin care, sun care, and color cosmetics.
• Laura Riffner will work with the executive leadership team to build on growth momentum and achieve long-term value creation.
• Jess Jankowski will serve as Board Advisor until his retirement on November 21, 2025, ensuring a smooth transition.
• The company will continue to pursue pathways for growth and shape the future of beauty through industry-leading skin health products.

Key Dates

Recommendation

The company is undergoing a positive strategic transformation, marked by a recent rebranding and Nasdaq uplisting, which enhances its market position and visibility. The appointment of an experienced internal leader as CEO and a highly qualified external CFO signals a strong commitment to future growth and operational excellence. These leadership changes, coupled with a clear strategic focus on high-performance beauty and life science solutions, position Solsence favorably for long-term value creation, making it an attractive investment.

Keywords

Solsence, SLSN, Leadership Change, CEO Appointment, CFO Appointment, Corporate Governance, Skin Care, Beauty Science, Sun Care, Cosmetics, Nanomaterials, Executive Transition, Nasdaq Uplisting